Not Yet RecruitingNCT07659938
Frontal Gamma Coherence Neurofeedback for Patients With Schizophrenia
Device studyAges 18–55United States
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.
- Listed locations
- La JollaSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: April 2027
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- BioSignal Solutions LLC
- Sponsor type
- Other organization
- Study type
- Device
- Intervention type
- Device
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT07659938
- Official title
Show the full official title
Preliminary Placebo-Controlled Double-Blind Randomized Clinical Trial of Mobile Platform to Improve Memory From Home or Office for Patients With Schizophrenia
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
La Jolla
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is BioSignal Solutions LLC.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
